Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥484m2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥1.8bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥1.3bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income−¥96m2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥111m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income−¥124m2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥268m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥238m2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax−¥112m2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥291m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)−¥99m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥348m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥249m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income−¥99m2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥251m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥8.5bnat 2023-09-30Cons.Assets
Total assets¥8.4bnat 2023-03-31Cons.Assets
Total assets¥8.4bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥594mat 2023-09-30Cons.Liabilities
Total liabilities¥426mat 2023-03-31Cons.Liabilities
Net assets / equity¥7.9bnat 2023-09-30Cons.Net assets
Net assets / equity¥8.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥7.9bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.9bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥3.0bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥2.9bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥3.0bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.6bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.8bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow−¥44m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥755m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥409m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥65m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥769m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥777m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥45m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥364m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥362m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-10.992023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-8.832023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥38.472022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥27.592022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.72022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio90.9%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio93.1%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio92.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥192m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥418m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥418m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥75m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥66m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥66m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥20m
—segment totalrevenue2023-04-01 → 2023-09-30¥484m
—segment totalrevenue external2023-04-01 → 2023-09-30¥484m
—segment totalsegment profit2023-04-01 → 2023-09-30¥95m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥484m
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥484m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥95m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥241m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥623m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥623m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥258m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥643m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥643m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥94m
—segment totalrevenue2022-04-01 → 2022-09-30¥1.3bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥1.3bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥353m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥353m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 530
ItemContextValueUnit
Comprehensive incomePrior1YTDDuration253000000JPY
Comprehensive incomeCurrentYTDDuration-94000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration256000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration-94000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-2000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-JPY
Income before income taxesPrior1YTDDuration291000000JPY
Income before income taxesCurrentYTDDuration-112000000JPY
Depreciation and amortization ope cfPrior1YTDDuration48000000JPY
Depreciation and amortization ope cfCurrentYTDDuration31000000JPY
Increase decrease in provision ope cfPrior1YTDDuration-122000000JPY
Increase decrease in provision ope cfCurrentYTDDuration53000000JPY
Interest income ope cfPrior1YTDDuration-0JPY
Interest income ope cfCurrentYTDDuration-0JPY
Interest expenses ope cfPrior1YTDDuration2000000JPY
Interest expenses ope cfCurrentYTDDuration-JPY
Equity in earnings losses of affiliates ope cfPrior1YTDDuration-107000000JPY
Equity in earnings losses of affiliates ope cfCurrentYTDDuration6000000JPY
Reversal of loss on valuation of investments in capital ope cfPrior1YTDDuration-JPY
Reversal of loss on valuation of investments in capital ope cfCurrentYTDDuration-1000000JPY
Insurance income ope cfPrior1YTDDuration-JPY
Insurance income ope cfCurrentYTDDuration-9000000JPY
Expenses related to the aquisition of subsidiary stocks ope cfPrior1YTDDuration-JPY
Expenses related to the aquisition of subsidiary stocks ope cfCurrentYTDDuration21000000JPY
Special audit fees ope cfPrior1YTDDuration10000000JPY
Special audit fees ope cfCurrentYTDDuration-JPY
Loss on liquidation of subsidiaries and affiliates ope cfPrior1YTDDuration24000000JPY
Loss on liquidation of subsidiaries and affiliates ope cfCurrentYTDDuration-JPY
Share based compensation expenses ope cfPrior1YTDDuration54000000JPY
Share based compensation expenses ope cfCurrentYTDDuration19000000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration29000000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration6000000JPY
Decrease increase in operating loans receivable ope cfPrior1YTDDuration-10000000JPY
Decrease increase in operating loans receivable ope cfCurrentYTDDuration-77000000JPY
Decrease increase in real estate for sale ope cfPrior1YTDDuration435000000JPY
Decrease increase in real estate for sale ope cfCurrentYTDDuration-JPY
Decrease increase in prepaid expenses ope cfPrior1YTDDuration64000000JPY
Decrease increase in prepaid expenses ope cfCurrentYTDDuration1000000JPY
Decrease increase in lease and guarantee deposits ope cfPrior1YTDDuration4000000JPY
Decrease increase in lease and guarantee deposits ope cfCurrentYTDDuration-JPY
Increase decrease in advances received ope cfPrior1YTDDuration-9000000JPY
Increase decrease in advances received ope cfCurrentYTDDuration1000000JPY
Increase decrease in accounts payable other ope cfPrior1YTDDuration-97000000JPY
Increase decrease in accounts payable other ope cfCurrentYTDDuration48000000JPY
Increase decrease in lease and guarantee deposits received ope cfPrior1YTDDuration-80000000JPY
Increase decrease in lease and guarantee deposits received ope cfCurrentYTDDuration-JPY
Increase decrease in accrued consumption taxes ope cfPrior1YTDDuration-52000000JPY
Increase decrease in accrued consumption taxes ope cfCurrentYTDDuration12000000JPY
Decrease increase in consumption taxes refund receivable ope cfPrior1YTDDuration64000000JPY
Decrease increase in consumption taxes refund receivable ope cfCurrentYTDDuration1000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass